Venture Capital

The MTA's major investment in Wabtec's hybrid locomotives promises cleaner air for New York, safer work for crews, and a more reliable subway system.

China's EngineAI unveils its powerful T800 humanoid at CES 2026, backed by massive funding and signaling a new era in the global robotics race.

Following record financial growth, RadNet promotes four executives to accelerate its shift toward proactive, AI-driven healthcare and expand its market dominance.

With new CEO Guillaume Bacuvier, process intelligence leader ARIS is betting its future on becoming the essential governance platform for Agentic AI.

A new multi-target deal combines cutting-edge platforms to create next-gen cancer drugs, aiming to improve precision and patient outcomes.

A new alliance pairs Relation's 'Lab-in-the-Loop' AI with Deerfield's investment might, aiming to fast-track novel drugs for intractable diseases.

With seasoned executive Adam Rosenberg at the helm, AstronauTx is advancing its novel sleep-focused therapy, backed by major investors, into the Alzheimer's arena.

At CES 2026, a powerful innovation engine called XbotPark & InnoX is showcasing over 40 AI hardware startups, revealing a new model for building tech giants.

Startup Guangfan Technology debuts vision-enabled AI earbuds at CES, promising a proactive assistant that sees your world. But is society ready for it?

As COO/CFO Ashim Gupta prepares for a key investor conference, UiPath aims to prove its 'agentic automation' strategy can deliver sustained growth.

With a $30.9M rights offering, Rare Element Resources aims to advance its Wyoming project, a key piece in America's race for rare earth independence.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

Singapore startup i10X secures $1M from top VCs to unify the fragmented AI landscape, offering a single platform for discovery and automation.

Dutch tech firm Aquablu unveils its BOLD system at CES, using AI and wearable data to deliver personalized, sustainable hydration to US offices and gyms.

Aegis Aerospace and United Semiconductors are building a chip factory in space. This Texas-backed venture could revolutionize tech and national security.

UBC's strategic buyout of AI-specialist Evidinno signals a major shift in evidence generation, promising faster, smarter data solutions for biopharma.

With new funding, the foundation aims to empower nurses on the front lines, fueling solutions for healthcare's most vulnerable populations.

With its lead asset TEC-001 targeting tough liver cancers, Teclison's presence at the ASCO GI Symposium puts its innovative approach in the spotlight.

For the sixth year, Ellucian is on the GSV 150 list. We explore how its AI-driven platform is reshaping higher education and what it means for students.

With a new CEO who has three FDA-approved drugs to his name, Catalio-backed Rhapsogen is poised to redefine autoimmune disease treatment. Here's why.